Company: Autolus Ltd
Job title: Senior Director, Patient & Cell Management
William Shingler is a PhD qualified biomedical scientist with over 15 years’ experience providing scientific, technical, and business leadership in biopharmaceutical drug development. He has expert knowledge of immuno-oncology, the drug development process (particularly clinical and CMC), and “Good Practice” quality systems and recently obtained a distinction in an executive MBA from the University of Oxford, Saïd Business School.
Having spent 18 months working with Novartis Apheresis Operations as UK technical lead for hospital site onboarding as part of the Kymriah launch programme, he is currently working with Autolus Ltd establishing and leading their Patient and Cell Management team.
Panel: Evaluating Whether the Use of Fresh or Frozen Leukapheresis is More Beneficial 9:05 am
• Evaluating the pros and cons of using fresh or frozen Leukapheresis • Assessing whether the use of fresh Leukapheresis is sustainable as patient numbers grows • Looking at emerging technologies that have promise in short-term storage of Leukapheresis • Analyzing the impact of fresh and frozen Leukapheresis on process performance and quality attributes of…Read more
day: Day Two
Round Tables: Advancing Standards to Cater for Both Clinical Trials and Commercial Operations, whilst Maintaining Chain of Identity 12:15 pm
• Developing standards that are suitable to new and small-size operations • Recognizing different needs of clinical and commercial operations to direct the requirements of future standards • Updating standards as clinical operations evolve to become commercial • Discussing the conflicts between corporate, hospital and shipping labelling requirements and finding a balance that shifts the…Read more
day: Day One